{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-055658","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2023-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.363085+00:00","generated_at":"2026-06-13T10:34:46.037870+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intensity Therapeutics closes full exercise of IPO over-allotment, raises $22.425M gross","bullets":["Total gross proceeds from upsized IPO and full over-allotment exercise: $22.425 million.","Underwriters exercised option to purchase 585,000 additional shares at $5.00, adding $2.925M gross.","Net proceeds to Intensity after underwriting discounts and expenses: approximately $18.9 million.","Joint book-running managers: The Benchmark Company and Freedom Capital Markets.","Closing and full exercise announced July 10, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-055658","json":"https://secwatch.observer/filing/0001213900-23-055658.json","markdown":"https://secwatch.observer/filing/0001213900-23-055658.md","text":"https://secwatch.observer/filing/0001213900-23-055658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000121390023055658/0001213900-23-055658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000121390023055658/ea181449-8k_intensity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:34:46.037870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}